Department of Bone and Soft Tissue Tumors, Peking University Cancer Hospital, Associate Chief Physician 【Professional Expertise】 With years of experience in the field of bone and soft tissue tumors, specializes in the standardized comprehensive treatment of primary benign and malignant bone and soft tissue tumors, with particular emphasis on the deep integration of surgical procedures with individualized treatment plans. In clinical practice, has extensive experience in surgical treatment, enabling precise assessment of tumor invasion range, formulation of safe and effective resection strategies, and maximal preservation of patients' limb function. Additionally, focuses on the surgical treatment of malignant melanoma, establishing a complete diagnostic and therapeutic system from precise tumor resection to postoperative recurrence prevention and control. Furthermore, actively participates in multidisciplinary tumor collaboration (MDT), accumulating unique experience in preoperative neoadjuvant chemotherapy for malignant bone tumors, postoperative adjuvant therapy, and prevention and management of complications. Has participated in clinical observational studies related to chemotherapy for soft tissue sarcomas, providing practical evidence for optimizing treatment regimens. 【Social Appointments (≤5 items)】 Member of the Committee for Surgical Treatment of Hematological Diseases, China Medical Education Association; Member of the Committee for Tumor Treatment, Chinese Association of Integrative Medicine 【Talent Title/Academic Experience】 Visiting Scholar at MD Anderson Cancer Center, USA 【Representative Achievements】 Published multiple papers in SCI and Peking University Core journals.